AltAssets is the private equity news and research service from Almeida Capital
AltAssets HomeAlmeida Capital websiteAlmeida Capital

 

PRINT THIS PAGE

Clinical transformation and the value of a cross-industry perspective

13/07/2004Source:Deloitte Research.  

Unlike most other aspects of society, the healthcare industry has been relatively unaffected by the recent revolution in information technology. But the ability to take advantage of advances in information technology will be crucial in determining the winners and losers in the life sciences arena going forward, according to Deloitte Research.

In many industries, such as banking, airlines and retailing, the impact of IT innovations have been nothing short of transformative. It remains to be seen whether the true potential of clinical IT in healthcare will be realised.

Click here to view the full report (pdf 300kb)

You need Adobe Acrobat to read this document. If you do not have it, you can download it free from www.adobe.com/products/acrobat/readstep.html

Operating through a network of research professionals, senior accounting and consulting practitioners, academics and technology partners, Deloitte Research identifies, analyzes and explains the major issues confronting businesses today and shaping tomorrow's marketplace. From provocative points of view about strategy and organizational change to straight talk about economics, regulation and technology, Deloitte Research delivers innovative, practical insights companies can use to improve their performance and gain competitive advantage.

top of the page

  Advanced Search

HOME | ABOUT US | CONTRIBUTE | FAQ | ADVERTISING | RSS FEED | WEEKLY NEWSLETTER SIGN-UP | CONTACT US

AltAssets is a service offered by Almeida Capital's Research Division. Available online at www.AltAssets.net
Almeida Capital Ltd is regulated by FSA and registered in England (no. 3945728). Registered Office: Acre House, 11-15 William Road, London NW1 3ER. Legals & Terms of Use
Content is © AltAssets 2000-2008

Subscribe to our newsletter Subscribe to our newsletter